CDKN2B and persistent truncus arteriosus: Here we show that the protein expression of the cell cycle inhibitor, p15 (which is decreased in a setting of lung fibrosis) was increased with LNA-antimiR-154 treatment in TAC hearts compared to TAC LNA-control hearts.